|
(ÁÖ)½ì¹ÙÀÌ¿ÀÅØ |
[ÇÁ·Î¹ÙÀÌ¿Àƽ½º ¼öÃâ 1À§ ±â¾÷] Áß±¹ ÇØ¿Ü¿µ¾÷ ä¿ë
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
07.14 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Business Insight & Analytics specialist
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
5³â¡è |
ä¿ë½Ã |
08.08 |
|
|
PPD Korea |
[PPD] ä¿ë°ø°í - Home-Based + JOINING BONUS - CRA II Opp
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.03 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] MCE Lead
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°æ¿µ/Àü·«±âȹ/ÄÁ¼³Æà |
5³â¡è |
ä¿ë½Ã |
12.10 |
|
|
EIS CORPORATION |
¶ó¹Ì³ª¸®¾Æ Á¦Á¶ ¹× »ý»ê À¯°æÇèÀÚ ¸ðÁý
ÀÎõ ºÎÆò±¸ | Çз¹«°ü |
»ý»ê/»ý»ê°ü¸® |
1³â¡è |
»ó½Ãä¿ë |
09.10 |
|
|
ÇÑ°á¸ÞµðÄ® |
Á¤Çü¿Ü°ú ¿µ¾÷,¿µ¾÷°ü¸®
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
°ø°³Ã¤¿ë |
1³â¡è |
ä¿ë½Ã |
09.16 |
|
|
¿À½ºÅÛÀÓÇöõÆ® |
¿À½ºÅÛÀÓÇöõÆ® Á¤º¸½Ã½ºÅÛ±âȹ ºÐ¾ß ä¿ë°ø°í
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Çϵå¿þ¾î¼³°è/°³¹ß |
7³â¡è |
ä¿ë½Ã |
08.22 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] (Sr.) Product Manager
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
08.20 |
|
|
(ÁÖ)ÆÛ½¼ |
ÇØ¿Ü ¿Â¶óÀÎ ¸¶ÄÉÆà °æ·ÂÀÚ Ã¤¿ë
¼¿ï ±Ýõ±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¸¶ÄÉÆÃ/±âȹ/±³À° |
5³â¡è |
ä¿ë½Ã |
03.08 |
|
|
PSI CRO Korea |
[PSI CRO Korea] ä¿ë Á¤º¸
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
08.31 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Legal Counsel
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ç¹«/Ãѹ«/¹ý¹«/ƯÇã |
5³â¡è |
ä¿ë½Ã |
07.24 |
|
|
ÈÞÁ©(ÁÖ) |
[½Å¾à¹ÙÀÌ¿À¿¬±¸ÆÀ] ¾àÈ¿Æò°¡ °æ·Â
°¿ø Ãáõ½Ã | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
3³â¡è |
ä¿ë½Ã |
11.07 |
|
|
(ÁÖ)Ƽ¾Ø¾Ë¹ÙÀÌ¿ÀÆÕ |
Á¦¾à, ÀÇ·á±â±â ÇØ¿Ü¿µ¾÷ ´ã´ç ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
1³â¡è |
ä¿ë½Ã |
12.26 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Medical Representative Respiratory (¼¿ï
¼¿ï ¼Ãʱ¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
1³â¡è |
ä¿ë½Ã |
10.28 |
|
|
(ÁÖ) »ç³ëÇÇ-¾Æº¥Æ¼½ºÄÚ¸®¾Æ |
[Sanofi/»ç³ëÇÇ] Vaccine Representative, Busan
ºÎ»ê ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
5³â¡è |
ä¿ë½Ã |
11.19 |
|